在组织扩张中,ACE2通过Ang II抑制皮肤再生
Ruoxue Bai1, Baoyan Liang1, Yaotao Guo1
1Department of Plastic and Reconstructive Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Journal of cosmetic dermatology
|January 20, 2025
概括
机械压力会增加 ангиотензин转化酶2 (ACE2) 的表达,促进皮肤的再生. 抑制ACE2增强了原蛋白合成和皮肤厚度,提高了组织扩张的有效性.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 皮肤病学 皮肤病学
背景情况:
- 组织扩张对于重建性手术至关重要,但面临着有限的扩张和组织脆弱性的挑战.
- ангиотензин转化酶2 (ACE2) 已知用于组织再生,但其在扩张期间皮肤更新中的作用尚不清楚.
- 这项研究调查了ACE2在扩张皮肤中的皮肤再生和原蛋白合成方面的具体贡献.
研究的目的:
- 阐明 ангиотензин转化酶2 (ACE2) 在组织扩张期间皮肤再生中的作用.
- 为了检查ACE2对扩大皮肤中的原蛋白合成和皮肤完整性的影响.
- 探索调节ACE2以增强组织扩张的治疗潜力.
主要方法:
- 分析了ACE2的表达和分布在老鼠和人类的扩展皮肤样本和体外拉伸的角质细胞中.
- 用ACE2淘汰赛角质细胞与纤维细胞一起评估增殖和迁移,ACE2酶活性被MLN-4760抑制.
- 关键参数包括扩大的皮肤大小,皮肤厚度,原蛋白I (COL I),原蛋白III (COL III) 和TGF-β水平被量化.
主要成果:
- 增加的ACE2表达与扩大皮肤的皮肤稀释相关,机械应激增加了ACE2表达和酶活性.
- 通过Angiotensin II (Ang II),ACE2促进了人类皮肤纤维细胞的迁移和增殖.
- 在体内,ACE2抑制剂MLN-4760通过上调COL I,COL III和TGF-β的调节,改善了皮肤再生和减少皮肤稀疏.
结论:
- 机械拉伸可以调节ACE2的表达,从而促进皮肤的再生.
- 抑制ACE2促进原合成和皮肤厚度,这表明改善组织扩张的治疗策略.
- 这项研究为利用ACE2调制来提高组织扩张程序的临床疗效提供了基础.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
577
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
577
Mechanism of Angiogenesis
5.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
378
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
378
Overview of Regeneration and Repair
3.9K
Regeneration and repair processes are critical in healing damages caused by injury, disease, and aging. In regeneration, the damaged tissue is entirely replaced with new growth that restores the original architecture and function. In contrast, tissue repair usually results in a fixed tissue architecture involving scar formation. Scars generally do not reestablish tissue function and may also exhibit structural abnormalities at the injury site.
Regeneration
All animals have varying degrees of...
Regeneration
All animals have varying degrees of...
3.9K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


